LeMaitre Vascular Inc. (LMAT)
86.09
2.60 (3.11%)
At close: Mar 24, 2025, 3:59 PM
86.07
-0.02%
After-hours: Mar 24, 2025, 04:37 PM EDT
3.11% (1D)
| Bid | 79 |
| Market Cap | 1.94B |
| Revenue (ttm) | 220.38M |
| Net Income (ttm) | 44.14M |
| EPS (ttm) | 1.93 |
| PE Ratio (ttm) | 44.61 |
| Forward PE | 46.44 |
| Analyst | Buy |
| Ask | 86.13 |
| Volume | 116,405 |
| Avg. Volume (20D) | 211,837 |
| Open | 84.81 |
| Previous Close | 83.49 |
| Day's Range | 84.17 - 86.34 |
| 52-Week Range | 62.39 - 109.58 |
| Beta | 0.88 |
About LMAT
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vas...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Oct 19, 2006
Employees 651
Stock Exchange NASDAQ
Ticker Symbol LMAT
Website https://www.lemaitre.com
Analyst Forecast
According to 9 analyst ratings, the average rating for LMAT stock is "Buy." The 12-month stock price forecast is $100, which is an increase of 16.16% from the latest price.
Stock ForecastsNext Earnings Release
LeMaitre Vascular Inc. is scheduled to release its earnings on May 1, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
-8.07%
LeMaitre Vascular shares are trading lower after B...
Unlock content with
Pro Subscription
3 weeks ago
-3.05%
LeMaitre Vascular shares are trading lower after the company reported worse-than-expected Q4 sales results.
